[{"address1": "1776 Yorktown", "address2": "Suite 550", "city": "Houston", "state": "TX", "zip": "77056", "country": "United States", "phone": "(832) 260-0222", "website": "https://www.nexalin.com", "industry": "Medical Devices", "sector": "Healthcare", "longBusinessSummary": "Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.", "fullTimeEmployees": 6, "companyOfficers": [{"maxAge": 1, "name": "Ms. Marilyn  Elson", "age": 70, "title": "Controller", "yearBorn": 1953, "fiscalYear": 2023, "totalPay": 382720, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  White", "age": 61, "title": "President, CEO, CFO & Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 191292, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Patrick Claude", "title": "Co-Founder and Director of Engineering & Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Owens M.D.", "age": 62, "title": "Chief Medical Officer & Director", "yearBorn": 1961, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Nketiah", "age": 47, "title": "Senior Vice-President of Quality, Regulatory & Clinical Affairs", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 251603, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.61, "open": 1.61, "dayLow": 1.43, "dayHigh": 1.64, "regularMarketPreviousClose": 1.61, "regularMarketOpen": 1.61, "regularMarketDayLow": 1.43, "regularMarketDayHigh": 1.64, "volume": 51492, "regularMarketVolume": 51492, "averageVolume": 832411, "averageVolume10days": 124230, "averageDailyVolume10Day": 124230, "bid": 1.4, "ask": 1.47, "bidSize": 100, "askSize": 100, "marketCap": 10671463, "fiftyTwoWeekLow": 0.253, "fiftyTwoWeekHigh": 3.4, "priceToSalesTrailing12Months": 96.35806, "fiftyDayAverage": 1.15332, "twoHundredDayAverage": 0.614935, "currency": "USD", "enterpriseValue": 7727496, "floatShares": 5893178, "sharesOutstanding": 7436560, "sharesShort": 327190, "sharesShortPriorMonth": 160491, "sharesShortPreviousMonthDate": 1710460800, "dateShortInterest": 1713139200, "sharesPercentSharesOut": 0.044, "heldPercentInsiders": 0.2292, "heldPercentInstitutions": 0.0064499998, "shortRatio": 0.22, "shortPercentOfFloat": 0.0554, "bookValue": 0.431, "priceToBook": 3.3294663, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -4648709, "trailingEps": -0.63, "enterpriseToRevenue": 69.775, "enterpriseToEbitda": -1.358, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "NXL", "underlyingSymbol": "NXL", "shortName": "Nexalin Technology, Inc.", "longName": "Nexalin Technology, Inc.", "firstTradeDateEpochUtc": 1663335000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "89a9bd26-da35-3349-b37a-a80d55d9b163", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.435, "recommendationKey": "none", "totalCash": 2948433, "totalCashPerShare": 0.396, "ebitda": -5692042, "totalDebt": 4463, "quickRatio": 6.955, "currentRatio": 8.065, "totalRevenue": 110748, "debtToEquity": 0.139, "revenuePerShare": 0.015, "returnOnAssets": -0.64356005, "returnOnEquity": -1.07047, "freeCashflow": -2103410, "operatingCashflow": -3835384, "revenueGrowth": -0.466, "grossMargins": 0.76805, "operatingMargins": -79.10367, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-05-04"}]